genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
REGENXBIO
Bioprocessing
A New-Wave Biosensor Approach for Direct, Fast, and High-Throughput AAV Process Development
Kathy Vuksanaj
-
June 6, 2023
22
Drug Discovery
Gene Therapy Pioneers Share Genome Editing Insights at Chardan Conference
Alex Philippidis
-
October 24, 2022
0
Genome Editing
Dimension Therapeutics Spurns Regenxbio for Sweeter Ultragenyx Offer
GEN Staff Writer
-
October 2, 2017
0
Genome Editing
Ultragenyx Offers $138M for Dimension Therapeutics, as Bidding War with Regenxbio Looms
GEN Staff Writer
-
September 18, 2017
0
Genome Editing
Regenxbio to Acquire Dimension Therapeutics
GEN Staff Writer
-
August 25, 2017
0
Genome Editing
Voyager Exercises Options for Regenx Gene Therapy Vectors
GEN Staff Writer
-
November 29, 2016
0
Industry News
Biogen Licenses Regenxbio Vectors
GEN Staff Writer
-
May 16, 2016
0
Genome Editing
Newly Capitalized REGENXBIO Targets Gene Therapy Market
GEN Staff Writer
-
September 18, 2015
0
Genome Editing
Voyager Licenses ReGenX’ NAV Vectors to Develop CNS Disease Gene Therapies
GEN Staff Writer
-
June 2, 2014
0
Genome Editing
ReGenX, Esteve to Develop Sanfilippo Syndrome Treatments
GEN Staff Writer
-
March 10, 2014
0
1
2
Page 1 of 2
Scroll Up